Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Other Non Operating Income: 2012-2025

Historic Other Non Operating Income for Ptc Therapeutics (PTCT) over the last 14 years, with Sep 2025 value amounting to $6.5 million.

  • Ptc Therapeutics' Other Non Operating Income rose 447.33% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 102.53%. This contributed to the annual value of $6.5 million for FY2024, which is 104.76% up from last year.
  • Ptc Therapeutics' Other Non Operating Income amounted to $6.5 million in Q3 2025, which was up 213.33% from -$5.7 million recorded in Q2 2025.
  • In the past 5 years, Ptc Therapeutics' Other Non Operating Income registered a high of $35.1 million during Q4 2022, and its lowest value of -$128.7 million during Q4 2023.
  • Moreover, its 3-year median value for Other Non Operating Income was -$1.9 million (2024), whereas its average is -$12.4 million.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first slumped by 1,183.82% in 2022, then soared by 447.33% in 2025.
  • Quarterly analysis of 5 years shows Ptc Therapeutics' Other Non Operating Income stood at -$31.4 million in 2021, then surged by 212.02% to $35.1 million in 2022, then tumbled by 466.24% to -$128.7 million in 2023, then skyrocketed by 106.88% to $8.8 million in 2024, then spiked by 447.33% to $6.5 million in 2025.
  • Its Other Non Operating Income stands at $6.5 million for Q3 2025, versus -$5.7 million for Q2 2025 and -$6.3 million for Q1 2025.